ANGO AngioDynamics
AngioDynamics (ANGO) is expected to report earnings on October 5, 2026, before the market open. The consensus earnings estimate is a loss of $0.10 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +16.2% since its last earnings release on July 14, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About AngioDynamics
AngioDynamics Inc designs, manufactures and sells medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings.
Sector
Healthcare
Industry
Medical Instruments/Supply